|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.6 INR | -0.66% |
|
+2.26% | -9.57% |
| Mar. 29 | Syncom Formulations Limited Announces Board Changes | CI |
| Feb. 14 | Syncom Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Syncom Formulations (India) Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 598.36 million compared to INR 514 million a year ago. Revenue was INR 617.11 million compared to INR 543.8 million a year ago.
Net income was INR 43.96 million compared to INR 38.68 million a year ago. Basic earnings per share from continuing operations was INR 0.07. Diluted earnings per share from continuing operations was INR 0.07.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.57% | 154M | |
| +31.28% | 588B | |
| -3.41% | 364B | |
| +19.18% | 326B | |
| +5.22% | 285B | |
| +15.34% | 239B | |
| +10.06% | 210B | |
| -6.91% | 200B | |
| +9.66% | 167B | |
| -0.61% | 161B |
SYNCOM FORMULATIONS (INDIA) LIMITED 
